New Non-Executive Director appointed to CUH
Philippa Hird has been appointed as a Non-Executive Director of Cambridge University Hospitals NHS Foundation Trust (CUH), which runs Addenbrooke’s and The Rosie Hospitals.
Bio-Rad extends anti-idiotypic antibody and SpyCatcher Reagent ranges for bioanalysis and antibody drug development
Additions to Company’s Range of Bioanalytical Antibodies and Reagents Enhances Bioanalysis and Antibody-Related Research
The ILD patient journey and what to expect
Navigating the journey of interstitial lung disease (ILD) can be overwhelming, filled with uncertainties, misdiagnoses, and emotional challenges. From the first signs of symptoms to receiving an accurate diagnosis and starting treatment, ILD patients often face a long and complex path.
Astoriom appoints Brittany Jackson as CFO
Key appointment to lead the company’s financial strategy and support continued global growth in sample stability and biorepository storage solutions
Sphere Bio expands operations in China
Exclusive agreement with specialist biotechnology distributor, Redbert Biotechnology, to strengthen international growth and market penetrationJohnathan Fu appointed as China Distribution Manager to lead regional partnerships and enhance customer support
Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
AI-enabled analytics platform demonstrates how real-world data used in place of human placebo and control groups can significantly reduce study costs and duration
Mursla Bio introduces AI precision medicine platform built on organ-specific EV isolation from blood
Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samplesEnables differentiated AI-powered biomarker discovery and IVD translation for patient stratification, therapeutic monitoring, su
Attribution modelling: A practical guide for science and tech marketers
A guide to attribution modelling, how to select the right model for you, and what you need to know about marketing systems that are critical to helping you connect every marketing touchpoint to real ROI and make smarter, data-driven decisions.
Biomedical Research with Health Databanks: Privacy and Data Protection Considerations
In early April this year, Prime Minister Starmer announced the UK government's plans to boost biomedical research by ensuring access to large sets of health data.
25 Years of Guardtech: Compliance Manager Chris McGinn Q&A
One of the Group’s longest-serving stalwarts gives his take on why quality and compliance is so critical to keeping Guardtech at the apex of the industry’s cleanroom construction providers
SolasCure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers
Recognises the potential of Aurase Wound Gel to improve outcomes for individuals with calciphylaxis ulcers, a rare and life-threatening conditionRepresents a new indication for Aurase Wound Gel, currently in Phase II Clinical Trials for treatment of venous leg ulcers
The European health data space: Key features and opportunities for access and research
In a previous blog post, we briefly outlined the plans of the European Union (EU) to facilitate access to high-quality data for scientific research. Three main EU initiatives aim at enabling such access.
Privacy implications of secondary use of personal data for scientific research in the European Union
Scientific research is front and centre in innovation policies across Europe, and the European Union (EU)'s research agenda makes no exception.
Improving experience through reliable coverage
Improving Experience Through Reliable Coverage
UK Biobank: A case-study of biomedical research with Databanks and its privacy and data protection considerations
In a previous blog post, we outlined the typical privacy and data protection implications of conducting biomedical research using personal data from health databanks.
Kadans Science Partner completes construction of primary structure on purpose built laboratory building at Merlin Place, North Cambridge
Topping out ceremony gathered key stakeholders on Cambridge Wide Open Day to celebrate progress in development of new laboratory facilities139,000 sq ft of flexible lab and office space, due for completion Q3 2026Cambridge, UK, 13 June 2025:
The clock’s ticking for Windows 10: Are you ready?
14th October 2025.
Does that date look familiar? If you’re using Windows 10, it should. It’s the day Microsoft pulls free support for the operating system.
EFEC’s role in advancing UK-China life sciences collaboration at MTI Expo 2025
Excellence First Enterprise Consultancy Ltd (EFEC) continues to play a pivotal role in bridging the UK and China across education, talent, and innovation ecosystems, with a particular focus on life sciences and healthcare technology. At the 2025 UK Medical Technology Innovation Expo (MTI Expo 2025), EFEC’s activities underscored its position as a key facilitator of cross-border innovation and…
Accelerate@Babraham 2025 announces new cohort
Five new ventures secure the chance to be part of Babraham Research Campus - a leading location for early-stage life science start-ups.
Learn more about the Wilson Pro DAS
Every building presents its own connectivity challenges. Zinwave’s wideband DAS is engineered to adapt and perform in complex environments, delivering consistent and reliable coverage.
How surrogate models enhance medical device optimisation
Design optimisation is a fundamental step in developing innovative and efficient medical devices. Before committing to manufacturing prototypes, simulations and models are developed to indicate the expected performance of the medical device design. They offer great precision however, they are computationally expensive and time-consuming to develop, especially for iterative processes like…
Norovirus vaccines - closer than you think
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis, publishes a brand-new global demand assessment for new norovirus vaccines.
CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its C
Enhanced Genomics appoints Dietrich Stephan, Ph.D. as Chair of the Board to lead ambitious growth strategy
Appointment strengthens leadership team to drive strategy focused on harnessing 3D multi-omics to identify high-confidence, high-value therapeutic targets, to accelerate drug discovery
Kerry Elden joins Salus Wellness
The team at Salus are pleased to announce that Kerry Elden has joined Salus Wellness this month.